Abstract
PDAC is an aggressive disease and early infiltrates peripancreatic tissues and adjacent organs, and gives distant metastasis and peritoneal involvement, making often surgical resection impossible. About 80% of PDACs are inoperable at the time of diagnosis. However, even if radiologically resectable, some PDAC microscopically involves the resection margins (pancreatic, retroperitoneal, or biliary, the retroperitoneal being the most important because it cannot be evaluated intraoperatorially) resulting in a nonradical excision. Local aggressiveness consists in the invasion of contiguous structures and organs (spleen, stomach, left adrenal gland, colon, and peritoneum), whereas distant metastases can occur in liver, lungs, adrenals, kidneys, bones, brain, and skin.
Most PDACs arise in the head of the pancreas often involving and occluding the intrapancreatic biliary duct and the main pancreatic duct, typically resulting in their upstream dilation associated with jaundice and cholangitis when the former is involved, and cystic formation with a variable degree of scleroatrophy of the surrounding parenchyma when the latter is involved. PDAC can spread through the papilla of Vater and duodenal wall with or without ulceration, raising the problem of differential diagnosis with primary duodenal and ampulla of Vater carcinomas infiltrating the pancreatic parenchyma. Less frequently, PDACs occur in the tail, where they are usually larger at diagnosis, determining weaker symptoms mainly due to loco-regional invasiveness.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Basturk O, Coban I, Adsay NV (2009) Pancreatic cysts: pathologic classification, differential diagnosis, and clinical implications. Arch Pathol Lab Med 133:423–438
Bellizzi AM, Stelow EB (2009) Pancreatic cytopathology: a practical approach and review. Arch Pathos Lab Med 133:388–404
Couch FJ, Johnson MR, Rabe K et al (2005) Germ line Fanconi anemia complementation group C mutations and pancreatic cancer. Cancer Res 65:383–386
Cubilla A, Fitzgerald P (1984) Tumours of the exocrine pancreas – Atlas of tumor pathology. Armed Forces Institute of Pathology, Washington, D.C.
Furukawa T, Kloppel G, Volkan Adsay N et al (2005) Classification of types of intraductal papillarymucinous neoplasm of the pancreas: a consensus study. Virchows Arch 447:794–799
Goggins M, Schutte M, Lu J et al (1996) Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 56:5360–5364
Hamilton S, Aaltonen L (2000) Pathology and genetics of tumors of the digestive system. IARC Press, Lyon
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70
Harada T, Chelala C, Bhakta V et al (2008) Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays. Oncogene 27:1951–1960
Harsha HC, Kandasamy K, Ranganathan P et al (2009) A compendium of potential biomarkers of pancreatic cancer. PLoS Med 6:e1000046
Hruban RH, Takaori K, Klimstra DS et al (2004) An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 28:977–987
Hruban RH, Klein AP, Eshleman JR, Axilbund JE, Goggins M (2007) Familial pancreatic cancer: from genes to improved patient care. Expert Rev Gastroenterol Hepatol 1:81–88
Ischenko I, Seeliger H, Schaffer M, Jauch KW, Bruns CJ (2008) Cancer stem cells: how can we target them? Curr Med Chem 15:3171–3184
Jones S, Zhang X, Parsons DW et al (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801–1806
Katoh Y, Katoh M (2006) Hedgehog signaling pathway and gastrointestinal stem cell signaling network (review). Int J Mol Med 18:1019–1023
Kim MP, Evans DB, Vu TM, Fleming JB (2009) The recognition and surgical management of heritable lesions of the pancreas. Surg Oncol Clin N Am 18:99–119; ix
Klein AP, Brune KA, Petersen GM et al (2004) Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 64:2634–2638
Klimstra DS, Pitman MB, Hruban RH (2009) An algorithmic approach to the diagnosis of pancreatic neoplasms. Arch Pathol Lab Med 133:454–464
Kloppel G (1994) Pancreatic, nonendocrine tumours. In: Pancreatic pathology. Churchill Livingstone, Edinburgh
Kloppel G, Adsay NV (2009) Chronic pancreatitis and the differential diagnosis versus pancreatic cancer. Arch Pathol Lab Med 133:382–387
Kluijt I, Cats A, Fockens P, Nio Y, Gouma DJ, Bruno MJ (2009) Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance. J Clin Gastroenterol 43:853–857
Larghi A, Verna EC, Lecca PG, Costamagna G (2009) Screening for pancreatic cancer in high-risk individuals: a call for endoscopic ultrasound. Clin Cancer Res 15:1907–1914
Lewis BC (2006) Development of the pancreas and pancreatic cancer. Endocrinol Metab Clin North Am 35:397–404; xi
Lynch HT, Fusaro RM, Lynch JF (2007) Hereditary cancer syndrome diagnosis: molecular genetic clues and cancer control. Future Oncol 3:169–181
Maitra A, Hruban RH (2008) Pancreatic cancer. Annu Rev Pathol 3:157–188
Ottenhof NA, Milne AN, Morsink FH et al (2009) Pancreatic intraepithelial neoplasia and pancreatic tumorigenesis: of mice and men. Arch Pathol Lab Med 133:375–381
Pawlik TM, Gleisner AL, Cameron JL et al (2007) Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 141:610–618
Riediger H, Keck T, Wellner U et al (2009) The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg 13:1337–1344
Sohn TA, Yeo CJ, Cameron JL et al (2004) Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 239:788–797; discussion 97–99
van der Heijden MS, Yeo CJ, Hruban RH, Kern SE (2003) Fanconi anemia gene mutations in young-onset pancreatic cancer. Cancer Res 63:2585–2588
van der Heijden MS, Brody JR, Dezentje DA et al (2005) In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor. Clin Cancer Res 11:7508–7515
Wang Z, Zhang Y, Banerjee S, Li Y, Sarkar FH (2006) Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer 106:2503–2513
Westgaard A, Schjolberg AR, Cvancarova M, Eide TJ, Clausen OP, Gladhaug IP (2009) Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours. Histopathology 54:337–347
Wilentz RE, Albores-Saavedra J, Zahurak M et al (1999) Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas. Am J Surg Pathol 23:1320–1327
Yamamoto H, Itoh F, Nakamura H et al (2001) Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability. Cancer Res 61:3139–3144
Zamboni G, Scarpa A, Bogina G et al (1999) Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol 23:410–422
Zamboni G, Capelli P, Pesci A, Beghelli S, Luttges J, Kloppel G (2000) Pancreatic head mass: what can be done? Classification: the pathological point of view. JOP 1:77–84
Zamboni G, Capelli P, Scarpa A et al (2009) Nonneoplastic mimickers of pancreatic neoplasms. Arch Pathol Lab Med 133:439–453
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Scarpa, A., Capelli, P., Cataldo, I. (2010). Pathology and Genetics. In: Laghi, A. (eds) New Concepts in Diagnosis and Therapy of Pancreatic Adenocarcinoma. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2010_4
Download citation
DOI: https://doi.org/10.1007/174_2010_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-85380-0
Online ISBN: 978-3-540-85381-7
eBook Packages: MedicineMedicine (R0)